Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.57 USD | -2.97% | -10.22% | -32.77% |
Apr. 09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
Apr. 03 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.54M |
---|---|---|---|---|---|
Net income 2022 | -5M | Net income 2023 | -6M | EV / Sales 2022 | - |
Net cash position 2022 | 37.48M | Net cash position 2023 | 30.1M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.42
x | P/E ratio 2023 |
-0.23
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.57% |
1 day | -2.97% | ||
1 week | -10.22% | ||
Current month | -3.59% | ||
1 month | -5.28% | ||
3 months | -6.76% | ||
6 months | -29.31% | ||
Current year | -32.77% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 13-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 16-11-13 |
Joshua Silverman
CHM | Chairman | 53 | 16-08-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4.57 | -2.97% | 28,924 |
24-05-09 | 4.71 | +1.29% | 35,371 |
24-05-08 | 4.65 | -0.64% | 38,974 |
24-05-07 | 4.68 | -0.64% | 77,711 |
24-05-06 | 4.71 | -7.47% | 57,994 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-32.77% | 4.96M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- SNPX Stock